Table 3 Prevalence of MetS components according to FPG and HbA1c criteria
Model | No. of components | IDF | NCEP ATP III | WHO |
|---|---|---|---|---|
Model 1 | 0 | 19 (7.2) | 27 (10.2) | 36 (13.6) |
1 | 47 (17.8) | 64 (24.2) | 48 (18.2) | |
2 | 70 (26.5) | 75 (28.4) | 81 (30.7) | |
3 | 72 (27.3) | 68 (25.8) | 62 (23.5) | |
4 | 47 (17.8) | 26 (9.8) | 32 (12.1) | |
5 | 9 (3.4) | 4 (1.5) | 5 (1.9) | |
Model 2 | 0 | 3 (1.1) | 6 (2.3) | 18 (6.8) |
1 | 41 (15.5) | 50 (18.9) | 43 (16.3) | |
2 | 65 (24.6) | 69 (26.1) | 64 (24.2) | |
3 | 79 (29.9) | 76 (28.8) | 96 (36.4) | |
4 | 60 (22.7) | 51 (19.3) | 33 (12.5) | |
5 | 16 (6.1) | 12 (4.5) | 10 (3.8) |